← Insider Monitor
Q32 Bio Inc. logo
QTTB

Q32 Bio Inc.

Nasdaq · Pharmaceutical Preparations

3
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Q32 Bio Inc. is a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory diseases, including conditions affecting the skin and kidneys, by targeting dysregulated immune pathways.

Industry
Pharmaceutical Preparations
Headquarters
Waltham, MA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Morrison Jodie PopeCEOSell$27KOct 6, 2026
Kalowski LeeCFO and PresidentSell$11KOct 6, 2026
Violette Shelia M.Chief Scientific OfficerSell$8KOct 6, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for QTTB.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable QTTB activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.